Quantitative Investment Management, LLC Gilead Sciences, Inc. Transaction History

Quantitative Investment Management, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$71.58 - $87.29 $13.2 Million - $16.1 Million	-183,976 Reduced 83.72%	35,780 $2.62 Million
Q4 2023 Feb 13, 2024	BUY	$73.27 - $83.09 $16.1 Million - $18.3 Million	219,756 New	219,756 $17.8 Million
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $1.35 Million - $1.54 Million	17,476 New	17,476 $1.45 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $1.81 Million - $2.07 Million	30,468 New	30,468 $1.88 Million
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $6.13 Million - $6.96 Million	-94,543 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $3.35 Million - $3.62 Million	-49,533 Reduced 34.38%	94,543 $6.6 Million
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $6.46 Million - $7.06 Million	101,857 Added 241.26%	144,076 $9.92 Million
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $2.53 Million - $2.89 Million	42,219 New	42,219 $2.73 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $18.5 Million - $23.7 Million	-296,019 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $10.9 Million - $12 Million	176,516 Added 147.71%	296,019 $19.2 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $26.7 Million - $29.5 Million	-427,757 Reduced 78.16%	119,503 $7.57 Million
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $33.9 Million - $38 Million	547,260 New	547,260 $37 Million
Q2 2018 Aug 10, 2018	SELL	$64.88 - $75.68 $16.1 Million - $18.8 Million	-248,900 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $18.1 Million - $22.1 Million	248,900 New	248,900 $18.8 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Quantitative Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Investment Management, LLC with notifications on news.